Cargando…

Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype

OBJECTIVE: To compare the reproductive, metabolic, and skeletal profiles of young athletic women with functional hypothalamic amenorrhea (FHA) as well as clinical or biochemical hyperandrogenism (FHA-EX+HA) with body mass index matched women with FHA due to exercise (FHA-EX) or anorexia nervosa (FHA...

Descripción completa

Detalles Bibliográficos
Autores principales: Javed, Asma, Kashyap, Rahul, Lteif, Aida N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298294/
https://www.ncbi.nlm.nih.gov/pubmed/25610004
http://dx.doi.org/10.2147/IJWH.S73011
_version_ 1782353247640485888
author Javed, Asma
Kashyap, Rahul
Lteif, Aida N
author_facet Javed, Asma
Kashyap, Rahul
Lteif, Aida N
author_sort Javed, Asma
collection PubMed
description OBJECTIVE: To compare the reproductive, metabolic, and skeletal profiles of young athletic women with functional hypothalamic amenorrhea (FHA) as well as clinical or biochemical hyperandrogenism (FHA-EX+HA) with body mass index matched women with FHA due to exercise (FHA-EX) or anorexia nervosa (FHA-AN) alone. DESIGN: Retrospective cohort study. SETTING: Tertiary care teaching hospital. POPULATION: Adolescents and young women, 15–30 years of age, diagnosed with FHA along with concurrent signs of hyperandrogenism (n=22) and body mass index matched control groups consisting of 22 women in each group of FHA-EX and FHA-AN. MAIN OUTCOMES: 1) Reproductive hormone profile: luteinizing hormone (LH), follicle stimulating hormone (FSH), total testosterone, pelvic ultrasound features. 2) Metabolic function and skeletal health markers: fasting glucose, cholesterol, number of stress fractures and bone mineral density as assessed by spine dual-energy X-ray absorptiometry z scores. RESULTS: FHA-EX+HA group was older at diagnosis compared to the other groups with a median (interquartile range [IQR]) age of 22 (18.75–25.25) years versus (vs) 17.5 (15.75–19) for FHA-EX; (P<0.01) and 18 (16–22.25) years for FHA-AN (P=0.01). There were no differences among the groups based on number of hours of exercise per week, type of physical activity or duration of amenorrhea. Median (IQR) LH/FSH ratio was higher in FHA-EX+HA than both other groups, 1.44 (1.03–1.77) vs 0.50 (0.20–0.94) for FHA-EX and 0.67 (0.51–0.87) for FHA-AN (P<0.01 for both). Total testosterone concentrations were not different among the groups. Median (IQR) fasting serum glucose concentration was higher in FHA-EX+HA vs FHA-EX, 88.5 mg/dL (82.8–90 mg/dL) vs 83.5 mg/dL (78.8–86.3 mg/dL) (P=0.01) but not different from FHA-AN (P=0.31). Percentage of women with stress fractures was lower in FHA-EX+HA (4.5%) as compared to both FHA-EX (27.3%) and FHA-AN (50%); P=0.04 and 0.01 respectively. The LH/FSH ratio was weakly positively associated with serum glucose (adjusted r(2)=0.102; P=0.01) as well as with dual-energy X-ray absorptiometry spine score (adjusted r(2)=0.191; P=0.04) in the entire cohort. CONCLUSION: In a small cohort of female athletes with hyperandrogenism, a distinct reproductive hormone profile consisting of higher LH to FHS ratio may be associated with adverse metabolic health markers but improved skeletal health.
format Online
Article
Text
id pubmed-4298294
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42982942015-01-21 Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype Javed, Asma Kashyap, Rahul Lteif, Aida N Int J Womens Health Original Research OBJECTIVE: To compare the reproductive, metabolic, and skeletal profiles of young athletic women with functional hypothalamic amenorrhea (FHA) as well as clinical or biochemical hyperandrogenism (FHA-EX+HA) with body mass index matched women with FHA due to exercise (FHA-EX) or anorexia nervosa (FHA-AN) alone. DESIGN: Retrospective cohort study. SETTING: Tertiary care teaching hospital. POPULATION: Adolescents and young women, 15–30 years of age, diagnosed with FHA along with concurrent signs of hyperandrogenism (n=22) and body mass index matched control groups consisting of 22 women in each group of FHA-EX and FHA-AN. MAIN OUTCOMES: 1) Reproductive hormone profile: luteinizing hormone (LH), follicle stimulating hormone (FSH), total testosterone, pelvic ultrasound features. 2) Metabolic function and skeletal health markers: fasting glucose, cholesterol, number of stress fractures and bone mineral density as assessed by spine dual-energy X-ray absorptiometry z scores. RESULTS: FHA-EX+HA group was older at diagnosis compared to the other groups with a median (interquartile range [IQR]) age of 22 (18.75–25.25) years versus (vs) 17.5 (15.75–19) for FHA-EX; (P<0.01) and 18 (16–22.25) years for FHA-AN (P=0.01). There were no differences among the groups based on number of hours of exercise per week, type of physical activity or duration of amenorrhea. Median (IQR) LH/FSH ratio was higher in FHA-EX+HA than both other groups, 1.44 (1.03–1.77) vs 0.50 (0.20–0.94) for FHA-EX and 0.67 (0.51–0.87) for FHA-AN (P<0.01 for both). Total testosterone concentrations were not different among the groups. Median (IQR) fasting serum glucose concentration was higher in FHA-EX+HA vs FHA-EX, 88.5 mg/dL (82.8–90 mg/dL) vs 83.5 mg/dL (78.8–86.3 mg/dL) (P=0.01) but not different from FHA-AN (P=0.31). Percentage of women with stress fractures was lower in FHA-EX+HA (4.5%) as compared to both FHA-EX (27.3%) and FHA-AN (50%); P=0.04 and 0.01 respectively. The LH/FSH ratio was weakly positively associated with serum glucose (adjusted r(2)=0.102; P=0.01) as well as with dual-energy X-ray absorptiometry spine score (adjusted r(2)=0.191; P=0.04) in the entire cohort. CONCLUSION: In a small cohort of female athletes with hyperandrogenism, a distinct reproductive hormone profile consisting of higher LH to FHS ratio may be associated with adverse metabolic health markers but improved skeletal health. Dove Medical Press 2015-01-13 /pmc/articles/PMC4298294/ /pubmed/25610004 http://dx.doi.org/10.2147/IJWH.S73011 Text en © 2015 Javed et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Javed, Asma
Kashyap, Rahul
Lteif, Aida N
Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype
title Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype
title_full Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype
title_fullStr Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype
title_full_unstemmed Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype
title_short Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype
title_sort hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298294/
https://www.ncbi.nlm.nih.gov/pubmed/25610004
http://dx.doi.org/10.2147/IJWH.S73011
work_keys_str_mv AT javedasma hyperandrogenisminfemaleathleteswithfunctionalhypothalamicamenorrheaadistinctphenotype
AT kashyaprahul hyperandrogenisminfemaleathleteswithfunctionalhypothalamicamenorrheaadistinctphenotype
AT lteifaidan hyperandrogenisminfemaleathleteswithfunctionalhypothalamicamenorrheaadistinctphenotype